Table 1 Baseline data of lung adenocarcinoma (LUAD) samples
From: GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma
Characteristics | Number | Percent (%) |
|---|---|---|
Age | Â | Â |
≥ 65 | 310 | 53.0 |
< 65 | 256 | 43.8 |
NA | 19 | 3.2 |
Location | Â | Â |
Central lung | 67 | 11.5 |
Peripheral lung | 130 | 22.2 |
NA | 388 | 66.3 |
Years_smoked | Â | Â |
≥ 41 | 160 | 27.4 |
< 41 | 234 | 40.0 |
NA | 191 | 32.6 |
pathologic_M | Â | Â |
M0 | 394 | 67.4 |
M1 | 20 | 3.4 |
M1a | 2 | 0.3 |
M1b | 5 | 0.9 |
MX | 158 | 27.0 |
NA | 6 | 1.0 |
pathologic_N | Â | Â |
N0 | 371 | 63.4 |
N1 | 107 | 18.3 |
N2 | 87 | 14.9 |
N3 | 2 | 0.3 |
NX | 17 | 2.9 |
NA | 1 | 0.2 |
pathologic_T | Â | Â |
T1 | 82 | 14.0 |
T1a | 49 | 8.4 |
T1b | 60 | 10.3 |
T2 | 203 | 34.7 |
T2a | 89 | 15.2 |
T2b | 29 | 5.0 |
T3 | 50 | 8.5 |
T4 | 20 | 3.4 |
TX | 3 | 0.5 |
radiation_therapy | Â | Â |
Yes | 69 | 11.8 |
No | 428 | 73.2 |
NA | 88 | 15.0 |
Gender | Â | Â |
Female | 316 | 54.0 |
Male | 269 | 46.0 |
tumor_stage | Â | Â |
I | 316 | 54.0 |
II | 135 | 23.1 |
III | 97 | 16.6 |
IV | 28 | 4.8 |
NA | 9 | 1.5 |
GPC3 expression | Â | Â |
≥ 3.19 | 270 | 46.2 |
< 3.19 | 315 | 53.8 |